Prostate cancer trials recruiting in Rhode Island

All Prostate cancer trials nationally

Cities in Rhode Island

Recruiting trials in Rhode Island

• A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
  NCT07189403 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
  NCT06952803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Rhode Island: Providence
• A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
  NCT07192614 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Rhode Island: Providence
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07287150 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Rhode Island: Providence
• A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
  NCT03972657 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
  NCT05806515 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Rhode Island: Westerly
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Rhode Island: Providence, Warwick
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Rhode Island: Providence
• First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
  NCT07529717 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · Rhode Island: Providence
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
  NCT03452774 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Rhode Island: Providence
• Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
  NCT07181161 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 130 Years · Sex: Male · Rhode Island: Providence
• Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
  NCT05519449 · Phase: Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · Rhode Island: Providence